Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/Compare

LULU vs NKE

LULU and NKE side by side — valuation & fundamentals (public data).

Key statistics

LULU vs NKE key statistics
MetricLULUlululemon athletica inc.NKENIKE, Inc.
Market cap$10.14B—
P/E (TTM)7.917.1
P/B2.12—
P/S0.9x—
Revenue$11.09B(TTM)$46.40B(TTM)
Revenue growth (YoY)4.9%0.2%
Net income$1.42B(TTM)$3.11B(TTM)
Earnings growth (YoY)-13.0%-3.4%
EPS, diluted$12.15(TTM)$2.10(TTM)
EBIT margin19.9%8.4%
ROE33.0%20.9%
ROIC—23.5%
1y total return-40.9%-50.8%

Figures from SEC filings · for reference only · not investment advice

Growth of $10,000: LULU vs NKE

$10.0K$15.6K$7.3K2016-05-132026-09-16
MetricLULUNKE
End value$15.6K$7.3K
Total return+55.9%-27.4%
CAGR+4.4%-3.0%
Volatility40.9%32.2%
Sharpe0.21-0.06
Sortino0.29-0.09
Max drawdown-81.2%-77.9%

Based on 2600 common trading days, 2016-05-13 → 2026-09-16 · risk-free 4.11% (current short-Treasury, held constant)

A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.

Related comparisons

NKE vs LULUNKE vs SKXNKE vs UAALULU vs SKXAAPL vs MSFTGOOGL vs META

Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)